These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 7208581)

  • 41. Effects of controlled-release on the pharmacokinetics and absorption characteristics of a compound undergoing intestinal efflux in humans.
    Tubic M; Wagner D; Spahn-Langguth H; Weiler C; Wanitschke R; Böcher WO; Langguth P
    Eur J Pharm Sci; 2006 Nov; 29(3-4):231-9. PubMed ID: 16713700
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Transbuccal tablets of carbamazepine: formulation, release and absorption pattern.
    Giannola LI; De Caro V; Giandalia G; Siragusa MG; D'Angelo M; Lo Muzio L; Campisi G
    Int J Immunopathol Pharmacol; 2005; 18(3 Suppl):21-31. PubMed ID: 16848984
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluation of drug release kinetics from ibuprofen matrix tablets using HPMC.
    Shoaib MH; Tazeen J; Merchant HA; Yousuf RI
    Pak J Pharm Sci; 2006 Apr; 19(2):119-24. PubMed ID: 16751122
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [The dynamics of the drug release from suppositories. Part 5: Liberation of chlorpromazine from suppository bases (author's transl)].
    Pasich J; Drobnicka B; Kasprzyk A
    Pharmazie; 1981; 36(1):20. PubMed ID: 7220580
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Dissolution study of the gentin tablets].
    Tsagareishvili NT; Bakuridze AD; Kurdiani NG; Murtazashvili TZh
    Georgian Med News; 2006 Apr; (133):94-6. PubMed ID: 16705241
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In vitro detection of possible in vivo drug interactions. Part 2: A study of the effect of hydrochlorothiazide and frusemide on the partition coefficient and solubility characteristics of propranolol hydrochloride.
    Al-Janabi II; Anber SA; Fikrat HT
    Pharmazie; 1981; 36(7):485-8. PubMed ID: 7280000
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Preparation and in vitro evaluation of sustained release tablet formulations of diclofenac sodium.
    Savaşer A; Ozkan Y; Işimer A
    Farmaco; 2005 Feb; 60(2):171-7. PubMed ID: 15752476
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Enhancement of ketoprofen bioavailability by formation of microsponge tablets.
    Comoglu T; Savaşer A; Ozkan Y; Gönül N; Baykara T
    Pharmazie; 2007 Jan; 62(1):51-4. PubMed ID: 17294814
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Continuous in situ monitoring of the dissolution rate of solid pharmaceutical preparations using a multiple channel fiber-optic chemical sensor].
    Zhang QM; Ge JH; Mai ED; Su QZ; Chen J
    Yao Xue Xue Bao; 2003 Apr; 38(4):294-7. PubMed ID: 12889132
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A site-specific controlled-release system for metformin.
    Di Colo G; Zambito Y; Baggiani A; Carelli V; Serafini MF
    J Pharm Pharmacol; 2005 May; 57(5):565-71. PubMed ID: 15901345
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of WHO and US FDA biowaiver dissolution test conditions using bioequivalent doxycycline hyclate drug products.
    Strauch S; Jantratid E; Dressman JB
    J Pharm Pharmacol; 2009 Mar; 61(3):331-7. PubMed ID: 19222905
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In vitro comparison of the beaker, the rotating-basket and the column dissolution-rate methods.
    Bathe RV; Häfliger O; Langenbucher F; Schönleber D
    Pharm Acta Helv; 1975; 50(1-2):3-10. PubMed ID: 1114160
    [No Abstract]   [Full Text] [Related]  

  • 53. [On the pharmaceutical technology of film coating (author's transl)].
    Kala H; Dittgen M; Moldenhauer H; Zessin G
    Pharmazie; 1979 Nov; 34(11):755-65. PubMed ID: 397492
    [No Abstract]   [Full Text] [Related]  

  • 54. The coefficient of rolling resistance (CoRR) of some pharmaceutical tablets.
    Ketterhagen WR; Bharadwaj R; Hancock BC
    Int J Pharm; 2010 Jun; 392(1-2):107-10. PubMed ID: 20307633
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Contributions to the liberation of drugs from suspension ointments. Part 19: Studies on the interactions of hydroxyquinoline (salts) with ointment components (author's transl)].
    Heber B; Horsch W
    Pharmazie; 1982 Apr; 37(4):277-9. PubMed ID: 7100252
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [The desintegration mechanism of pharmaceutical tablets with starch (author's transl)].
    Couvreur P; Roland M
    J Pharm Belg; 1976; 31(5):511-32. PubMed ID: 993973
    [No Abstract]   [Full Text] [Related]  

  • 57. [Dynamics of the liberation of therapeutic substances from tablets. XXI. Comparison of 4 liberation models with Vasculat and Bupatol tablets as examples].
    Kasprzyk A; Pasich J
    Acta Pharm Hung; 1986 Mar; 56(2):49-53. PubMed ID: 2871690
    [No Abstract]   [Full Text] [Related]  

  • 58. [Contributions to the liberation of drugs from suspension ointments. Part 13: The effects of physiochemical factors on the liberation of prednisolone from oleogels (author's transl)].
    Horsch W; Löschburg M
    Pharmazie; 1981 Dec; 36(12):823-7. PubMed ID: 7330084
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Simulation of the disintegration process of pharmaceutical tablets.
    Colombo P; Ferrari F; Gazzaniga A; Caramella C; Conte U; La Manna A; Peppas NA
    Pharm Acta Helv; 1988; 63(8):221-3. PubMed ID: 3231654
    [No Abstract]   [Full Text] [Related]  

  • 60. Optimization of tablets containing a high dose of spray-dried plant extract: a technical note.
    Soares LA; Ortega GG; Petrovick PR; Schmidt PC
    AAPS PharmSciTech; 2005 Oct; 6(3):E367-71. PubMed ID: 16353994
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.